Carlumab (Anti-CCL2 / MCP1)
Carlumab (Anti-CCL2 / MCP1) is a humanised monoclonal antibody targeting CCL2 with high affinity. Carlumab can be used in cancer research, particularly in prostate cancer. MW:145.5 KD.
| Trivial name | CNTO 888 |
| Catalog Number | A2573 |
| CAS# | 915404-94-3 |
| Size | 1mg*25 |
| Supplier Page | http://www.selleckchem.com/products/carlumab-anti-ccl2-mcp1.html |